GenoLab M is our most powerful sequencing instrument to-date, we published the first report to compare the transcriptome and LncRNA sequencing data of the GenoLab M sequencer to NovaSeq 6000
We’re proud to publish a new study on BMC Genomics comparing the WGS and WES sequencing data of the GenoLab M sequencer to NoveSeq 6000 and NextSeq 550 sequencer in
A recent study published by BMC Genomics compared the relative performance of GenoLab M and Illumina NextSeq 2000 for 10x Genomics Visium spatial sequencing. In order to assess concordance of
The first hospital of LanZhou University and Genemind collaborated in a publication on BMC Medical Genomics， titled “Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and
GeneMind has carried out pre-clinical research and clinical verification of NIPT with a number of research centers led by the Obstetrics and Gynecology Hospital of Zhejiang University School of Medicine.
Detection of Copy Number Variation (CNV) in genetic material of abortion tissues includes extracting DNA from cells, single-molecule sequencing and bioinformatics analysis to reveal aneuploidy in any chromosomes and CNV
A research team jointly formed by the Professor Lin’s research group of Reproductive and Genetic Hospital of CITIC-Xiangya (hereinafter referred to as ’CITIC Xiangya’) and GeneMind Biosciences published a paper
On November 28, GeneMind officially launched the third self-developed sequencing system FASTASeq 300. GeneMind showcased the instrument at Medlab Middle East 2023, making its first worldwide debut at booth Z1.B39,
On March, GeneMind and Nanjing Jiangbei New District have reached a strategic partnership. The cooperation mainly focuses on promoting the industrialization and development of high-throughput sequencing technology. The two parties
